At the very least, there could be more transparency about the way these funds are flowing.
Janice Schakowsky
The Public Record
Janice D. Schakowsky is an American politician serving as the U.S. Representative for Illinois's 9th congressional district since 1999. A member of the Democratic Party, she has been a prominent advocate for various progressive issues, including healthcare reform, women's rights, and consumer protection. Schakowsky has played a significant role in shaping policies related to social justice and economic equality throughout her tenure in Congress.
How much? If you are going to use that as the excuse for raising the prices, then I think we have an absolute right to know how much is being spent.
The whining that is going on about having to talk about some transparency is really irritating to me.
My legislation, the FAIR Drug Pricing Act, H.R. 2296, is a bipartisan, bicameral bill that will force the drug companies to be transparent.
The pharmaceutical industry is worth almost ONE TRILLION dollars and they are holding American consumers hostage.
PhRMA is opposed to any legislation that would require pharmaceutical manufacturers to provide basic transparency to the American people.
For the first time ever, this bill will offer taxpayers nationwide notice of price increases and bring basic transparency to the market for prescription drugs.
My legislation, the Fair Drug Pricing Act, H.R. 2296, is a bipartisan, bicameral bill that will force the drug companies to be transparent.
Let me just remind everyone that the IRA stands for the organization that coordinated all of the online activities dealing with interference in the U.S. election. Madam Speaker, I yield to the gentlewoman from California (Ms. Speier) to…
I thank the gentleman for coming. I yield to the gentlewoman from Wisconsin (Ms. Moore) to read a quote from the Mueller report.
Even averages, I think, are really skewing toward the wealthiest Americans, because we have such a vast income inequality.
I volunteer at a food bank, and at the end of the month who do you see lining up? It's the seniors.
I think it would be a very wise move to deal with a class of compounds that is persistent, bioaccumulative, and toxic and mobile.
I welcome H.R. 2600 introduced by Representative Dean which takes the same approach for PFAS chemicals.
It was John Dingell's wisdom that led to the adoption of the PCB subsection and it stands now as one of the only actions EPA was able to take under the original TSCA.
We've even seen an increase in white working class men, whose longevity has taken a bit of a dive.
So many of the people--probably, I am sure, most of the people--that are living near poverty and relying just on their Social Security are women.
What this bill would require is that pharmaceutical manufacturers notify Health and Human Services
I do want to just call your attention to a bill I introduced that has to do with transparency
The cost of pharmaceuticals has reached a point that no one can really ignore it anymore
All the polling before the 2018 election said that the price of prescription drugs is the main problem that people are facing.
We hear all kinds of reasons to justify why these prices are skyrocketing, why people literally are dying because they can't afford their drugs.





